Other conditions of the proposed rule include the following:
• Implementation of the Part D coverage gap discount program.
• Expansion of Part D drug coverage to include benzodiazepines and, for specified health conditions, barbiturates.
• Expansion of benefits for dual-eligible patients.
• Ability for physicians to request reconsiderations with the Independent Review Entity on their patient’s behalf without obtaining a signed authorized representative form if a prescription is denied by a Part D plan.
• Requirement of Part D sponsors to provide, in certain cases, the option of a daily prorated cost-sharing rate for prescriptions for fewer than 30 days.
The proposed rule is open to a 60-day comment period.
Related Articles on CMS Proposed Rules:
HHS Publishes 2 Proposed Rules Regarding Affordable Health Coverage
CMS Issues Final IPPS Rule, Net Medicare Reimbursements to Increase 1.1%
CMS Releases Proposed Standards for CO-OP Insurance Plans
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
